Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering recombinant antibodies for immunotherapy

D Neri1, H Petrul, G Roncucci

  • 1Cambridge Centre for Protein Engineering, MRC Centre, United Kingdom.

Cell Biophysics
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor-targeted IL2 promotes specific CD8<sup>+</sup> T cells private clonal expansion enhancing lymphoma control.

Journal of experimental & clinical cancer research : CR·2026
Same author

Past, present and future of drug conjugates for cancer therapy.

Nature cancer·2025
Same author

Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Editorial: Plant root interaction with associated microbiomes to improve plant resiliency and crop biodiversity, volume II.

Frontiers in plant science·2023
Same author

Translational imaging of the fibroblast activation protein (FAP) using the new ligand [<sup>68</sup>Ga]Ga-OncoFAP-DOTAGA.

European journal of nuclear medicine and molecular imaging·2021
Same author

An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.

Leukemia·2017
Same journal

Syngeneic anti-idiotypic antibodies eliminate excess radiolabeled idiotypes at experimental radioimmunolocalization.

Cell biophysics·1995
Same journal

Animal models of human-derived cancer vaccines.

Cell biophysics·1995
Same journal

Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1 alpha, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies.

Cell biophysics·1995
Same journal

Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers.

Cell biophysics·1995
Same journal

Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines.

Cell biophysics·1995
Same journal

Linkage of silver to antibodies through 2-imino thiolane.

Cell biophysics·1995
See all related articles

High-affinity recombinant antibody fragments are generated using phage display and antibody libraries. Effective transformation into immunotherapeutic agents requires specific engineering, purification, and functionalization strategies for clinical use.

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Recombinant antibody fragments offer high-affinity antigen binding.
  • Current methods yield fragments needing further processing for clinical use.

Purpose of the Study:

  • To outline procedures for transforming recombinant antibodies into immunotherapeutic agents.
  • To discuss key features for effective antibody functionalization.

Main Methods:

  • Phage display methodologies for antibody library construction.
  • Engineering techniques to enhance antibody binding affinity.
  • Purification and functionalization strategies for recombinant antibodies.

Main Results:

  • Successful generation of high-affinity antibody fragments.

Related Experiment Videos

  • Identification of critical steps for therapeutic antibody development.

    • Conclusions:

    • Recombinant antibody fragments can be effectively developed into immunotherapeutics.
    • Specific engineering, purification, and functionalization are crucial for clinical application.